ACO Name and Location Medicine Alliance for Patients, LLC 6704 Curtis Court Glen Burnie, Maryland 21060 ACO Primary Contact Primary Contact Name Primary Contact Phone Number 443-287-4519 Scott Berkowitz, MD, MBA Primary Contact Email Address Sberkow3@jhmi.edu Organizational Information ACO participants: ACO s Bellor Leichtling Saway & Schneider Pc (Columbia Medical Practice) Regional Physicians LLC (Cardiovascular Specialists of Central Maryland) The Hospital Suburban Hospital, Inc. Bayview Medical Center, Inc. Community Physicians Potomac Physician Associates Howard County General Hospital, Inc. Lucy Webb Hayes National Training School For Deaconesses Missionarie (Sibley Memorial Hospital) ACO in Joint Venture (Enter or N) ACO governing body: Last Name Member First Name Title/Position Baumgartner William Senior Vice President, Office of Physicians; Co-Chair, Member's Voting Power Membership Type ACO TIN Legal Business Name/DBA, if Applicable
Bennett Richard President, Johns Hopkins Bayview Medical Center; Berkowitz Scott Senior Medical Director, Accountable Care; Executive Director, JMAP Brown Patricia Senior Vice President, Managed Care and Population Health; President, HealthCare; Co- Chair, 1 Other N/A Eisle David Director, Otolaryngology; Feeser Scott Office Medical Director, Johns Hopkins Community Physicians, Remington Internal Medicine; Medical Director, JMAP Flynn John Vice President, Office of Physicians; Chief Medical Officer, JMAP Hussein Carlessia Jayaraman Uma Treasurer, Potomac Physician Associates; Kravet Steve President, Johns Hopkins Community Physicians; Deputy Vice President, Office of Physicians; Chief Quality Officer, JMAP Oberlander DeWayne Chief Executive Officer, Columbia Medical Practice; 1 Medicare Beneficiary Community Physicians N/A Potomac Physician Associates Community Physicians Columbia Medical Practice
Sheikh Saba Medical Director, Clinical Integration, Columbia Medical Practice; Voting Member, JMAP Board Schwartz Steve Medical Director, Potomac Physician Associates; Regional Medical Director, JMAP Columbia Medical Practice Potomac Physician Associates Key ACO clinical and administrative leadership: Scott Berkowitz ACO Executive Scott Feeser Medical Director Pamela Owens Compliance Officer Steve Kravet Quality Assurance/Improvement Officer Associated committees and committee leadership: Committee Name Medical and Quality Committee Beneficiary Advisory Committee Compliance Committee Analytics Committee Regional Advisory Councils Committee Leader Name and Position Steve Kravet, Co-Chair John Flynn, Co-Chair Carlessia Hussein, Co-Chair Scott Feeser, Medical Director, Co-Chair Pamela Owens, Compliance Officer Sarah Kachur, Co-Chair Jenny Bailey, Co-Chair Scott Berkowitz, ACO Executive Scott Feeser, Medical Director Types of ACO participants, or combinations of participants, that formed the ACO: ACO professionals in a group practice arrangement Networks of individual practices of ACO professionals Partnerships or joint venture arrangements between hospitals and ACO professionals
Shared Savings and Losses Amount of Shared Savings/Losses First Agreement Period o Performance ear 2016, $0 o Performance ear 2015, $0 o Performance ear 2014, $0 Shared Savings Distribution First Agreement Period o Performance ear 2016 Proportion invested in infrastructure: N/A Proportion invested in redesigned care processes/resources: N/A Proportion of distribution to ACO participants: N/A o Performance ear 2015 Proportion invested in infrastructure: N/A Proportion invested in redesigned care processes/resources: N/A Proportion of distribution to ACO participants: N/A o Performance ear 2014 Proportion invested in infrastructure: N/A Proportion invested in redesigned care processes/resources: N/A Proportion of distribution to ACO participants: N/A
Quality Performance Results 2016 Quality Performance Results: ACO# Measure Name Rate ACO Mean 1 CAHPS: Getting Timely Care, Appointments, and Information 79.84 80.51 2 CAHPS: How Well our Providers Communicate 92.80 93.01 3 CAHPS: Patients Rating of Provider 92.17 92.25 4 CAHPS: Access to Specialists 83.86 83.49 5 CAHPS: Health Promotion and Education 62.80 60.32 6 CAHPS: Shared Decision Making 73.42 75.40 7 CAHPS: Health Status/Functional Status 74.85 72.30 34 CAHPS: Stewardship of Patient Resources 18.47 26.97 8 Risk Standardized, All Condition Readmission 14.49 14.70 35 36 37 38 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 15.67 18.17 All-Cause Unplanned Admissions for Patients with Diabetes 51.00 53.20 All-Cause Unplanned Admissions for Patients with Heart Failure 70.51 75.23 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 57.01 59.81 9 10 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 11.75 9.27 16.76 14.53 11 39 13 14 15 Percent of PCPs who Successfully Meet Meaningful Use Requirements 98.86 82.72 Documentation of Current Medications in the Medical Record 99.32 87.54 Falls: Screening for Future Fall Risk 79.45 64.04 Preventive Care and Screening: Influenza Immunization 65.37 68.32 Pneumonia Vaccination Status for Older Adults 85.91 69.21 16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 69.13 74.45
17 18 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Preventive Care and Screening: Screening for Clinical Depression and Followup Plan 94.04 90.98 76.67 53.63 19 20 Colorectal Cancer Screening 68.14 61.52 Breast Cancer Screening 55.32 67.61 21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 80.56 76.79 42 27 41 28 30 Statin therapy for the Prevention and Treatment of Cardiovascular Disease 83.00 77.72 Diabetes Mellitus: Hemoglobin A1c Poor Control 19.64 18.24 Diabetes: Eye Exam 56.07 44.94 Hypertension (HTN): Controlling High Blood Pressure 59.35 70.69 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 92.00 85.05 31 33 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 95.49 88.67 90.91 79.67 Please note, the 40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples. For 2016 Quality Performance Results please visit: https://data.cms.gov/special-programs- Initiatives-Medicare-Shared-Savin/2016-Shared-Savings-Program-SSP-Accountable-Care- O/3jk5-q6dr/data For 2015 Quality Performance Results please visit: https://data.cms.gov/special-programs- Initiatives-Medicare-Shared-Savin/Medicare-Shared-Savings -Program-Accountable-Care-O/x8vaz7cu For 2014 Quality Performance Results please visit: https://data.cms.gov/special-programs- Initiatives-Medicare-Shared-Savin/Medicare-Shared-Savings -Program-Accountable-Care-O/uccehhpu Note: In the Quality Performance Results file(s) above, search for Medicine Alliance for Patients, LLC to view the quality performance results. This ACO can also be found by using the ACO ID A79168 in the public use files on data.cms.gov. Payment Rule Waivers No, our ACO does not use the SNF 3-Day Rule Waiver.